Mounjaro (generic name: tirzepatide) is covered by Japan’s public health insurance when a doctor decides it is needed to treat type 2 diabetes. It is not covered for weight-loss or cosmetic purposes; in that case it is self-pay treatment and you pay the full cost.
After the drug price revision on August 1, 2026, the drug cost of using Mounjaro 2.5 mg once weekly for 4 weeks is ¥5,772, or about ¥1,732 with a 30% copay. For 5 mg, a common maintenance dose, the drug cost is ¥11,544, or about ¥3,463 with a 30% copay. However, your actual out-of-pocket payment may also include consultation fees, test fees, the home self-injection management fee, dispensing fees and other charges.
The short answerBusy? Just read this part
- Insurance coverage for Mounjaro applies to the treatment of type 2 diabetes. Obesity or a high BMI alone does not qualify for insurance coverage.
- After the August 2026 revision, the 30% copay for 4 weeks of drug cost is about ¥1,732 for 2.5 mg and about ¥3,463 for 5 mg.
- If you use Mounjaro for weight-loss or cosmetic purposes, it is off-label use under self-pay treatment and you pay the full cost.
- Zepbound, which contains the same active ingredient, is a treatment for obesity disease, but insurance coverage has strict requirements regarding BMI, health problems, treatment history, the medical institution and more.
- When asking “how much is it with insurance?”, check the total cost, including not only the drug cost but also consultation, tests, the home self-injection management fee and dispensing fees.
Is Mounjaro covered by health insurance? The answer first
Insurance coverage for Mounjaro applies to the treatment of type 2 diabetes. Obesity or a high BMI alone does not qualify for insurance coverage.
| Purpose / drug | Public health insurance | Points to check |
|---|---|---|
| Mounjaro used to treat type 2 diabetes | Covered when a doctor decides it is medically necessary and the requirements for insurance-covered care are met | Being diagnosed with type 2 diabetes does not by itself guarantee a prescription |
| Mounjaro used for weight-loss or cosmetic purposes | Not covered | Off-label use under self-pay treatment; you pay the full cost |
| Zepbound used to treat obesity disease | Covered when all specified patient and facility requirements are met | Different brand name and approved indications from Mounjaro |
The indication approved for Mounjaro in Japan is type 2 diabetes. Even though weight loss has been reported, Mounjaro cannot be used under insurance-covered care just because you “want to lose weight” or “have fatty liver.”
In insurance-covered care, the doctor checks your type 2 diabetes status, diet and exercise therapy, blood sugar control, past medical history, other medications and more, and decides whether drug treatment is necessary and safe. Asking for Mounjaro does not guarantee that it will be prescribed.
How much is Mounjaro with insurance? Drug prices after the August 2026 revision
According to the Ministry of Health, Labour and Welfare’s medical fee information service, the drug prices for Mounjaro from August 1, 2026 are as follows. The table shows the drug cost for 4 weeks of once-weekly dosing and approximate 10–30% copay amounts.
| Dose | Price per pen | 4 weeks | 10% copay | 20% copay | 30% copay |
|---|---|---|---|---|---|
| 2.5mg | ¥1,443 | ¥5,772 | About ¥577 | About ¥1,154 | About ¥1,732 |
| 5mg | ¥2,886 | ¥11,544 | About ¥1,154 | About ¥2,309 | About ¥3,463 |
| 7.5mg | ¥4,329 | ¥17,316 | About ¥1,732 | About ¥3,463 | About ¥5,195 |
| 10mg | ¥5,772 | ¥23,088 | About ¥2,309 | About ¥4,618 | About ¥6,926 |
| 12.5mg | ¥7,215 | ¥28,860 | About ¥2,886 | About ¥5,772 | About ¥8,658 |
| 15mg | ¥8,658 | ¥34,632 | About ¥3,463 | About ¥6,926 | About ¥10,390 |
*The Japanese original is authoritative.
Approximate figures calculated simply from the drug prices effective August 1, 2026, as 1 pen × 4 weeks, rounded to the nearest yen. Your actual payment will vary depending on the number of doses, calculation method, and copay rate based on age and income.
The table above shows Mounjaro’s drug cost only. In practice, first-visit and follow-up visit fees, test fees, the home self-injection management fee, prescription and dispensing fees, and the cost of other medications may be added. Please check the exact amount with the medical institution and pharmacy you visit.
Conditions for Mounjaro to be covered by health insurance
The prerequisite for insurance coverage is that Mounjaro is used for its approved indication: the treatment of type 2 diabetes. During a consultation, the doctor mainly checks the following:
- Whether you have been diagnosed with type 2 diabetes
- How diet and exercise therapy have been carried out
- Test results such as blood sugar and HbA1c
- Use of other diabetes medications and their effect
- Risk of side effects, past medical history and other medications
There is no uniform rule such as “type 2 diabetes always means Mounjaro” or “a certain HbA1c value always means a prescription.” In line with the Japan Diabetes Society’s approach to drug therapy, the medication is chosen based on the condition, age, complications, safety and other factors.
Is it covered if I have a high BMI or fatty liver?
Mounjaro is not covered by health insurance simply because you have a high BMI or fatty liver. Insurance-covered care with Mounjaro is premised on the treatment of type 2 diabetes.
Even if you have type 2 diabetes together with obesity, fatty liver or other conditions, the doctor makes an overall judgment on whether Mounjaro is appropriate. It cannot be billed to insurance as diabetes treatment for the purpose of weight loss alone.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
Mounjaro for weight loss is self-pay treatment
In Japan, using Mounjaro for weight-loss or cosmetic purposes is off-label use, differing from its approved indications. Public health insurance cannot be used, and you pay the full cost, including the consultation, medication, tests and shipping.
| Hiro Clinic dose | Drug cost (4 pens) | Including standard shipping |
|---|---|---|
| 2.5mg | ¥17,600 | ¥19,250 |
| 5mg | ¥25,920 | ¥27,570 |
| 7.5mg | ¥61,600 | ¥63,250 |
*The Japanese original is authoritative.
Tax incl., as of September 12, 2026. Calculated by adding the standard shipping fee of ¥1,650. Subscription delivery has a shipping fee of ¥660; Hokkaido and Okinawa have a shipping fee of ¥2,200. Additional costs may apply depending on the care provided. Please check the latest pricing page before applying.
How to get started from your first visit, consultation hours and refrigerated delivery are explained in detail in our guide to online consultation for Mounjaro.
Differences in insurance coverage between Mounjaro and Zepbound
Mounjaro and Zepbound both contain the active ingredient tirzepatide, but their approved indications in Japan and the conditions for insurance coverage differ.
| Comparison | Mounjaro | Zepbound |
|---|---|---|
| Active ingredient | Tirzepatide | |
| Main approved use | Type 2 diabetes | Obesity disease meeting certain conditions, etc. |
| Insurance coverage for obesity disease | Not covered as Mounjaro | Covered when patient, facility, treatment-history and other requirements are met |
For Zepbound to be covered by insurance for obesity disease, requirements include a diagnosis of at least one of high blood pressure, dyslipidemia or type 2 diabetes, and also meeting either “BMI of 35 or higher” or “BMI of 27 or higher with two or more obesity-related health problems.” In addition, appropriate diet and exercise therapy must have been carried out for 6 months or more without sufficient effect, and there are facility requirements such as specialist doctors and registered dietitians.
Having the same ingredient does not mean one can be freely substituted for the other. The doctor chooses the approved product according to the treatment purpose and diagnosis. For details, see also Mounjaro self-pay treatment and medical rules.
Not sure if it suits you? Start with a consultation.
A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.
No consultation fee (first & follow-up visits)Online consultation available
How to tell insurance-covered care from self-pay treatment
What condition is being treated:
Insurance-covered care with Mounjaro is premised on the treatment of type 2 diabetes.
Whether a diagnosis and tests are done:
A doctor examines you and checks your blood sugar, treatment history and more.
Whether the costs are clearly explained:
Check the total, including not only the drug cost but also the consultation, tests, self-injection guidance, dispensing and shipping.
Whether off-label use is explained:
For weight-loss purposes, you receive an explanation of how it differs from the approved scope and of the risks.
Whether there is someone to consult about side effects:
Check how follow-up after the prescription works and how to get in touch in an emergency.
About self-pay treatment and off-label use
Frequently asked questions about insurance coverage for Mounjaro
QHow much does Mounjaro cost per month with insurance?
At the drug prices after the August 2026 revision, the drug cost of using 2.5 mg for 4 weeks is ¥5,772, or about ¥1,732 with a 30% copay. For 5 mg, a common maintenance dose, it is ¥11,544, or about ¥3,463 with a 30% copay. Your actual out-of-pocket payment may also include consultation fees, test fees, the home self-injection management fee, dispensing fees and other charges.
QIs Mounjaro covered by insurance if my BMI is 25 or higher?
No. BMI alone does not determine insurance coverage for Mounjaro. Mounjaro’s approved indication is type 2 diabetes, and use for weight loss is self-pay treatment. Zepbound, a treatment for obesity disease, has separate requirements for BMI, health problems, treatment history and facilities.
QIs Mounjaro covered by insurance if I have fatty liver?
Mounjaro is not covered by insurance on the basis of fatty liver alone. Even if you also have type 2 diabetes, the doctor decides whether it is necessary based on your diabetes status, treatment history and other factors.
QHow long does insurance coverage for Mounjaro last?
When Mounjaro is used to treat type 2 diabetes, there is no fixed end date. The doctor decides whether to continue, change or stop it while checking its effect, side effects, test values and other treatment options. Please do not stop on your own.
QCan it be covered by insurance even for weight loss?
No. Using Mounjaro for cosmetic, slimming or weight-loss purposes is self-pay treatment. The Ministry of Health, Labour and Welfare also warns about health problems caused by careless use for purposes other than those approved.
QIf it is insurance-covered care, is it eligible for high-cost medical expense benefits?
Medical costs paid under insurance-covered care may be eligible for the High-Cost Medical Expense Benefit system if your out-of-pocket costs in the same month exceed the limit for your income bracket. Don’t judge based on Mounjaro’s drug cost alone; check with your health insurance provider. Self-pay treatment costs are not eligible.
Not sure? Talk to us
No consultation fee (first & follow-up visits)Online consultation available
Toll-free 0120-241-929 (toll-free in Japan, 9:00–18:00 JST, Japanese only)
Summary: insurance covers type 2 diabetes treatment; weight-loss use is self-pay
Mounjaro is covered by health insurance when a doctor decides it is needed to treat type 2 diabetes. A high BMI, obesity or fatty liver alone does not qualify for coverage. After the August 2026 revision, the drug cost for 4 weeks of 2.5 mg is ¥5,772, and the approximate 30% copay is about ¥1,732.
For weight loss, it is self-pay treatment, so check the total cost, including the consultation fee, tests and shipping in addition to the drug cost, as well as the support available after the prescription. At Hiro Clinic, a doctor checks your health through online consultation and explains whether a prescription is possible and the treatment plan.
References
- Ministry of Health, Labour and Welfare, medical fee information service: “Drug prices effective August 1, 2026”
- PMDA: “Mounjaro Subcutaneous Injection Ateos: prescription drug information”
- Ministry of Health, Labour and Welfare: “Optimal Use Promotion Guidelines for tirzepatide products (revised May 2026)”
- Ministry of Health, Labour and Welfare: “Beware of health problems from using Mounjaro, Rybelsus and similar drugs for cosmetic or slimming purposes”
This article is based on public sources and clinic information as of September 12, 2026. Drug prices, approval details, care arrangements and fees may change.



